ID   BPNT1_RAT               Reviewed;         308 AA.
AC   Q9Z1N4;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   24-JUL-2024, entry version 153.
DE   RecName: Full=3'(2'),5'-bisphosphate nucleotidase 1 {ECO:0000303|PubMed:10347153};
DE            EC=3.1.3.7 {ECO:0000269|PubMed:10347153};
DE   AltName: Full=3'-phosphoadenosine 5'-phosphate phosphatase {ECO:0000303|PubMed:10347153};
DE            Short=PAP phosphatase {ECO:0000303|PubMed:10347153};
DE   AltName: Full=Bisphosphate 3'-nucleotidase 1;
DE            Short=BPntase 1;
DE   AltName: Full=Inositol-polyphosphate 1-phosphatase {ECO:0000303|PubMed:10347153};
DE            EC=3.1.3.57 {ECO:0000269|PubMed:10347153};
DE   AltName: Full=RnPIP {ECO:0000303|PubMed:10347153, ECO:0000303|PubMed:11812139};
DE   AltName: Full=scHAL2 analogous 3;
GN   Name=Bpnt1; Synonyms=Sal3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, COFACTOR,
RP   SUBSTRATE SPECIFICITY, ACTIVITY REGULATION, BIOPHYSICOCHEMICAL PROPERTIES,
RP   AND TISSUE SPECIFICITY.
RC   TISSUE=Heart;
RX   PubMed=10347153; DOI=10.1074/jbc.274.23.16034;
RA   Lopez-Coronado J.M., Belles J.M., Lesage F., Serrano R., Rodriguez P.L.;
RT   "A novel mammalian lithium-sensitive enzyme with a dual enzymatic activity,
RT   3'-phosphoadenosine 5'-phosphate phosphatase and inositol-polyphosphate 1-
RT   phosphatase.";
RL   J. Biol. Chem. 274:16034-16039(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 28-40; 145-167; 202-217; 225-232; 262-274 AND 278-297,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Hippocampus, and Spinal cord;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q.;
RL   Submitted (APR-2007) to UniProtKB.
RN   [4]
RP   ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RA   Lubec G., Chen W.-Q.;
RL   Submitted (FEB-2007) to UniProtKB.
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.69 ANGSTROMS) OF 5-308 IN COMPLEX WITH AMP; MG(2+)
RP   AND PHOSPHATE, REACTION MECHANISM, AND ACTIVE SITE.
RX   PubMed=11812139; DOI=10.1006/jmbi.2001.5271;
RA   Patel S., Yenush L., Rodriguez P.L., Serrano R., Blundell T.L.;
RT   "Crystal structure of an enzyme displaying both inositol-polyphosphate-1-
RT   phosphatase and 3'-phosphoadenosine-5'-phosphate phosphatase activities: a
RT   novel target of lithium therapy.";
RL   J. Mol. Biol. 315:677-685(2002).
CC   -!- FUNCTION: Phosphatase that converts 3'(2')-phosphoadenosine 5'-
CC       phosphate (PAP) to AMP and adenosine 3'-phosphate 5'-phosphosulfate
CC       (PAPS) to adenosine 5'-phosphosulfate (APS). Is also able to hydrolyze
CC       inositol 1,4-bisphosphate (Ins(1,4)P2) and inositol 1,3,4-trisphosphate
CC       (Ins(1,3,4)P3), but is not active on AMP, 3'-AMP, fructose-1,6-
CC       bisphosphate, Ins(1)P, Ins(2)P and Ins(1,4,5)P3. Probably prevents the
CC       toxic accumulation of PAP, a compound which inhibits a variety of
CC       proteins, including PAPS-utilizing enzymes such as sulfotransferases,
CC       and RNA processing enzymes. Could also play a role in inositol
CC       recycling and phosphoinositide metabolism.
CC       {ECO:0000269|PubMed:10347153}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=adenosine 3',5'-bisphosphate + H2O = AMP + phosphate;
CC         Xref=Rhea:RHEA:10040, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:58343, ChEBI:CHEBI:456215; EC=3.1.3.7;
CC         Evidence={ECO:0000269|PubMed:10347153};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:10041;
CC         Evidence={ECO:0000305|PubMed:10347153};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=adenosine 2',5'-bisphosphate + H2O = AMP + phosphate;
CC         Xref=Rhea:RHEA:77643, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:194156, ChEBI:CHEBI:456215; EC=3.1.3.7;
CC         Evidence={ECO:0000269|PubMed:10347153};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:77644;
CC         Evidence={ECO:0000305|PubMed:10347153};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3'-phosphoadenylyl sulfate + H2O = adenosine 5'-phosphosulfate
CC         + phosphate; Xref=Rhea:RHEA:77639, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:58243, ChEBI:CHEBI:58339; EC=3.1.3.7;
CC         Evidence={ECO:0000269|PubMed:10347153};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:77640;
CC         Evidence={ECO:0000305|PubMed:10347153};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1D-myo-inositol 1,4-bisphosphate + H2O = 1D-myo-inositol 4-
CC         phosphate + phosphate; Xref=Rhea:RHEA:15553, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:58282, ChEBI:CHEBI:58469; EC=3.1.3.57;
CC         Evidence={ECO:0000269|PubMed:10347153};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:15554;
CC         Evidence={ECO:0000305|PubMed:10347153};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1D-myo-inositol 1,3,4-trisphosphate + H2O = 1D-myo-inositol
CC         3,4-bisphosphate + phosphate; Xref=Rhea:RHEA:70319,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:58414,
CC         ChEBI:CHEBI:83241; Evidence={ECO:0000269|PubMed:10347153};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70320;
CC         Evidence={ECO:0000305|PubMed:10347153};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:10347153};
CC       Note=Binds 3 Mg(2+) ions per subunit. {ECO:0000269|PubMed:11812139};
CC   -!- ACTIVITY REGULATION: Inhibited by Li(+) and Ca(2+), but not by Na(+).
CC       {ECO:0000269|PubMed:10347153}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.2 uM for 3'-phosphoadenylyl sulfate
CC         {ECO:0000269|PubMed:10347153};
CC         KM=0.2 uM for 1D-myo-inositol 1,4-bisphosphate
CC         {ECO:0000269|PubMed:10347153};
CC         Vmax=0.8 umol/min/mg enzyme with adenosine 3',5'-bisphosphate as
CC         substrate {ECO:0000269|PubMed:10347153};
CC         Vmax=0.4 umol/min/mg enzyme with 3'-phosphoadenylyl sulfate as
CC         substrate {ECO:0000269|PubMed:10347153};
CC         Vmax=0.38 umol/min/mg enzyme with 1D-myo-inositol 1,4-bisphosphate as
CC         substrate {ECO:0000269|PubMed:10347153};
CC         Note=KM for adenosine 3',5'-bisphosphate is below 2 uM.
CC         {ECO:0000269|PubMed:10347153};
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart, brain, spleen, lung,
CC       liver, skeletal muscle, kidney and testis.
CC       {ECO:0000269|PubMed:10347153}.
CC   -!- SIMILARITY: Belongs to the inositol monophosphatase superfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ000347; CAA04022.1; -; mRNA.
DR   EMBL; BC085692; AAH85692.1; -; mRNA.
DR   RefSeq; NP_741987.1; NM_171990.2.
DR   RefSeq; XP_006250493.1; XM_006250431.3.
DR   PDB; 1JP4; X-ray; 1.69 A; A=1-308.
DR   PDBsum; 1JP4; -.
DR   AlphaFoldDB; Q9Z1N4; -.
DR   SMR; Q9Z1N4; -.
DR   STRING; 10116.ENSRNOP00000071594; -.
DR   iPTMnet; Q9Z1N4; -.
DR   PhosphoSitePlus; Q9Z1N4; -.
DR   SwissPalm; Q9Z1N4; -.
DR   jPOST; Q9Z1N4; -.
DR   PaxDb; 10116-ENSRNOP00000003249; -.
DR   GeneID; 64473; -.
DR   KEGG; rno:64473; -.
DR   UCSC; RGD:621833; rat.
DR   AGR; RGD:621833; -.
DR   CTD; 10380; -.
DR   RGD; 621833; Bpnt1.
DR   VEuPathDB; HostDB:ENSRNOG00000002378; -.
DR   eggNOG; KOG3099; Eukaryota.
DR   HOGENOM; CLU_034742_2_0_1; -.
DR   InParanoid; Q9Z1N4; -.
DR   OrthoDB; 3665671at2759; -.
DR   PhylomeDB; Q9Z1N4; -.
DR   BRENDA; 3.1.3.57; 5301.
DR   Reactome; R-RNO-156584; Cytosolic sulfonation of small molecules.
DR   SABIO-RK; Q9Z1N4; -.
DR   EvolutionaryTrace; Q9Z1N4; -.
DR   PRO; PR:Q9Z1N4; -.
DR   Proteomes; UP000002494; Chromosome 13.
DR   Bgee; ENSRNOG00000002378; Expressed in duodenum and 20 other cell types or tissues.
DR   ExpressionAtlas; Q9Z1N4; baseline and differential.
DR   GO; GO:0008441; F:3'(2'),5'-bisphosphate nucleotidase activity; IDA:RGD.
DR   GO; GO:0004441; F:inositol-1,4-bisphosphate 1-phosphatase activity; IDA:RGD.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:RGD.
DR   GO; GO:0046854; P:phosphatidylinositol phosphate biosynthetic process; IEA:InterPro.
DR   CDD; cd01640; IPPase; 1.
DR   Gene3D; 3.40.190.80; -; 1.
DR   Gene3D; 3.30.540.10; Fructose-1,6-Bisphosphatase, subunit A, domain 1; 1.
DR   InterPro; IPR050725; CysQ/Inositol_MonoPase.
DR   InterPro; IPR020583; Inositol_monoP_metal-BS.
DR   InterPro; IPR000760; Inositol_monophosphatase-like.
DR   InterPro; IPR020550; Inositol_monophosphatase_CS.
DR   PANTHER; PTHR43028; 3'(2'),5'-BISPHOSPHATE NUCLEOTIDASE 1; 1.
DR   PANTHER; PTHR43028:SF5; 3'(2'),5'-BISPHOSPHATE NUCLEOTIDASE 1; 1.
DR   Pfam; PF00459; Inositol_P; 1.
DR   PRINTS; PR00377; IMPHPHTASES.
DR   SUPFAM; SSF56655; Carbohydrate phosphatase; 1.
DR   PROSITE; PS00629; IMP_1; 1.
DR   PROSITE; PS00630; IMP_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Direct protein sequencing; Hydrolase; Lithium;
KW   Magnesium; Metal-binding; Phosphoprotein; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|Ref.4"
FT   CHAIN           2..308
FT                   /note="3'(2'),5'-bisphosphate nucleotidase 1"
FT                   /id="PRO_0000142529"
FT   ACT_SITE        51
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305|PubMed:11812139"
FT   ACT_SITE        122
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305|PubMed:11812139"
FT   BINDING         74
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:11812139,
FT                   ECO:0007744|PDB:1JP4"
FT   BINDING         74
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000269|PubMed:11812139,
FT                   ECO:0007744|PDB:1JP4"
FT   BINDING         117
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:11812139,
FT                   ECO:0007744|PDB:1JP4"
FT   BINDING         117
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:11812139,
FT                   ECO:0007744|PDB:1JP4"
FT   BINDING         119
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:11812139,
FT                   ECO:0007744|PDB:1JP4"
FT   BINDING         120
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:11812139,
FT                   ECO:0007744|PDB:1JP4"
FT   BINDING         195
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000269|PubMed:11812139,
FT                   ECO:0007744|PDB:1JP4"
FT   BINDING         198
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000269|PubMed:11812139,
FT                   ECO:0007744|PDB:1JP4"
FT   BINDING         220
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000269|PubMed:11812139,
FT                   ECO:0007744|PDB:1JP4"
FT   BINDING         224
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000269|PubMed:11812139,
FT                   ECO:0007744|PDB:1JP4"
FT   BINDING         247
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:11812139,
FT                   ECO:0007744|PDB:1JP4"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|Ref.4"
FT   MOD_RES         122
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O95861"
FT   MOD_RES         240
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95861"
FT   MOD_RES         244
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z0S1"
FT   HELIX           7..32
FT                   /evidence="ECO:0007829|PDB:1JP4"
FT   STRAND          38..42
FT                   /evidence="ECO:0007829|PDB:1JP4"
FT   STRAND          45..47
FT                   /evidence="ECO:0007829|PDB:1JP4"
FT   HELIX           49..65
FT                   /evidence="ECO:0007829|PDB:1JP4"
FT   STRAND          69..75
FT                   /evidence="ECO:0007829|PDB:1JP4"
FT   HELIX           84..86
FT                   /evidence="ECO:0007829|PDB:1JP4"
FT   HELIX           93..96
FT                   /evidence="ECO:0007829|PDB:1JP4"
FT   HELIX           102..104
FT                   /evidence="ECO:0007829|PDB:1JP4"
FT   HELIX           109..111
FT                   /evidence="ECO:0007829|PDB:1JP4"
FT   STRAND          112..120
FT                   /evidence="ECO:0007829|PDB:1JP4"
FT   HELIX           122..126
FT                   /evidence="ECO:0007829|PDB:1JP4"
FT   HELIX           130..132
FT                   /evidence="ECO:0007829|PDB:1JP4"
FT   STRAND          134..141
FT                   /evidence="ECO:0007829|PDB:1JP4"
FT   STRAND          144..152
FT                   /evidence="ECO:0007829|PDB:1JP4"
FT   TURN            153..158
FT                   /evidence="ECO:0007829|PDB:1JP4"
FT   STRAND          167..172
FT                   /evidence="ECO:0007829|PDB:1JP4"
FT   TURN            173..175
FT                   /evidence="ECO:0007829|PDB:1JP4"
FT   STRAND          176..180
FT                   /evidence="ECO:0007829|PDB:1JP4"
FT   STRAND          191..198
FT                   /evidence="ECO:0007829|PDB:1JP4"
FT   HELIX           201..208
FT                   /evidence="ECO:0007829|PDB:1JP4"
FT   STRAND          213..219
FT                   /evidence="ECO:0007829|PDB:1JP4"
FT   HELIX           221..229
FT                   /evidence="ECO:0007829|PDB:1JP4"
FT   STRAND          234..238
FT                   /evidence="ECO:0007829|PDB:1JP4"
FT   HELIX           245..257
FT                   /evidence="ECO:0007829|PDB:1JP4"
FT   STRAND          261..263
FT                   /evidence="ECO:0007829|PDB:1JP4"
FT   STRAND          284..289
FT                   /evidence="ECO:0007829|PDB:1JP4"
FT   HELIX           291..297
FT                   /evidence="ECO:0007829|PDB:1JP4"
FT   HELIX           300..305
FT                   /evidence="ECO:0007829|PDB:1JP4"
SQ   SEQUENCE   308 AA;  33174 MW;  478C375057E88EC9 CRC64;
     MASSHNVLMR LVASAYSIAQ KAGTIVRCVI AEGDLGIVQK TSATDLQTKA DRMVQMSICS
     SLSRKFPKLT IIGEEDLPPG EVDQELIEDG QSEEILKQPC PSQYSAIKEE DLVVWVDPVD
     GTKEYTEGLL DNVTVLIGIA YEGKAIAGII NQPYYNYQAG PDAVLGRTIW GVLGLGAFGF
     QLKEAPAGKH IITTTRSHSN KLVTDCIAAM NPDNVLRVGG AGNKIIQLIE GKASAYVFAS
     PGCKKWDTCA PEVILHAVGG KLTDIHGNPL QYDKEVKHMN SAGVLAALRN YEYYASRVPE
     SVKSALIP
//
